The Trump administration is moving forward with plans to reclassify marijuana under Schedule III of the Controlled Substances Act, a move that will ease barriers to medical research into applications for cannabis and CBD products but will leave in place federal prohibitions on recreational use of the drug.
President Donald Trump announced the move during a Thursday Oval Office signing ceremony alongside cannabis industry representatives and Health and Human Services officials.